MedMen has terminated its deal to acquire Pharmacann. The cannabis license owner and retailer announced they were nixing the $682 million dollar all stock deal. Brian Lauvray, Head of Development and Strategy at MMLG joined Cheddar to discuss.
MedMen has terminated its deal to acquire Pharmacann. The cannabis license owner and retailer announced they were nixing the $682 million dollar all stock deal. Brian Lauvray, Head of Development and Strategy at MMLG joined Cheddar to discuss.